NUWE logo

Nuwellis, Inc. Stock Price

NasdaqCM:NUWE Community·US$2.5m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 4 Fair Values set on narratives written by author

NUWE Share Price Performance

US$2.69
-74.59 (-96.52%)
US$2.69
-74.59 (-96.52%)
Price US$2.69

NUWE Community Narratives

There are no narratives available yet.

Snowflake Analysis

Slight risk with mediocre balance sheet.

4 Risks
1 Reward

Nuwellis, Inc. Key Details

US$8.3m

Revenue

US$3.1m

Cost of Revenue

US$5.2m

Gross Profit

US$19.9m

Other Expenses

-US$14.7m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Nov 12, 2025
-16.26
62.35%
-176.42%
0%
View Full Analysis

About NUWE

Founded
1999
Employees
38
CEO
John Erb
WebsiteView website
www.nuwellis.com

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors in Austria, Belarus, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Indonesia, Israel, Italy, Panama, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

Recent NUWE News & Updates

Recent updates

No updates